Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
The healthcare giant is dealing with the fast-approaching patent cliff for its most important product, cancer medicine ...
Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, ...
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report). The ...
Sen. Elizabeth Warren, D-Mass., questions Robert F. Kennedy Jr., President Donald Trump's pick for Department of Health and Human Services secretary, as he testifies before the Senate Finance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback